Service and Maintenance for LSR Fortessa Flow Cytometer
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) has issued a Notice of Intent (NOI) to award a sole-source, firm-fixed-price contract to USBDB Service Contract Admin (BD Biosciences) for Service and Maintenance for an LSR Fortessa Flow Cytometer. This action is not a request for competitive proposals, but interested parties may submit capability statements by February 9, 2026.
Scope of Work
This requirement is for preventative maintenance and service for one (1) Government-owned LSR Fortessa Flow Cytometer (Serial No. R647800L6075), which is critical for ongoing cancer research and patient care at the NCI's Center for Cancer Research. Services must be performed by an Original Equipment Manufacturer (OEM)-Authorized Service Provider using OEM certified factory-trained technicians and OEM certified parts. The contractor will furnish all necessary services, qualified personnel, materials, equipment, and documentation, including onsite engineer calibrations and services, to maintain the equipment at OEM specifications.
Contract & Timeline
- Contract Type: Firm-fixed price with option periods.
- Estimated Period of Performance:
- Base: March 17, 2026 – March 16, 2027
- Option 1: March 17, 2027 – March 16, 2028
- Option 2: March 17, 2028 – March 16, 2029
- Place of Performance: National Institutes of Health, National Cancer Institute (NCI), Bethesda, MD.
- Response Date: February 9, 2026
- Published Date: January 30, 2026
Set-Aside & Justification
- NAICS Code: 811219 – Other Electronic and Precision Equipment Repair and Maintenance (Size Standard: $22M).
- Set-Aside Status: This acquisition is NOT set aside for small businesses; it is a sole-source acquisition to BD Biosciences.
- Justification: BD Biosciences is identified as the sole manufacturer and service provider for the LSR Fortessa flow cytometer. The NCI states that only BD Biosciences' factory-trained and certified technicians have access to proprietary parts, system schematics, software, and configurations necessary to maintain the equipment, ensure system integrity, prevent data loss, and uphold warranties. Use of any other contractor would void warranties and jeopardize research data.
Submission & Evaluation
This is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond. Submissions should include: unit price, list price, shipping and handling costs, delivery period, prompt payment discount terms, F.O.B. Point, DUNS number, UNIQUE ENTITY ID, TIN, and certification of business size. All offerors must have an active registration in SAM.gov. Responses will be considered solely to determine if a competitive procurement is feasible. Responses must be submitted electronically to Shayna.Simpson@hhs.gov by the closing date.
Primary Point of Contact
Shayna Simpson, Contract Specialist, Shayna.Simpson@hhs.gov